Production of medicinal products and medical materials in November 2021
In November 2021, Russian enterprises produced a wide range of medicines and medical materials. The table provides a complete breakdown by product type: from lysine and glutamic acid to complex compounds and finished dosage forms. For each item, production volumes for November and for the reporting period since the beginning of the year are given, along with unique OKPD2, OKEI and OKATO codes for accurate identification. The data cover the entire production chain without regional breakdown
Table of production of medicines and medical materials for November 2021
See also
- Electricity consumption in Russia by year long time series by year
Set in numbers
Rosstat data. Series: 474, indicators: 4. Table rows: Lysine, glutamic acid and their salts; quaternary salts and ...; Lysine, glutamic acid and their salts; quaternary salts and ...; Lysine, glutamic acid and their salts; quaternary salts and ...; Lysine, glutamic acid and their salts; quaternary salts and ...; Lysine, glutamic acid and their salts; quaternary salts and ... and others
Five highest values: Glands and other organs; their extracts and others... (664 264), Lysine, glutamic acid and their salts; quaternary s... (57 401), Lysine, glutamic acid and their salts; quaternary s... (37 930), Lysine, glutamic acid and their salts; quaternary s... (19 016), Lactones, not elsewhere specified; ... (643). The gap between the highest and lowest is 22 142 times. The top five account for 99.4% of the total across all positions — the distribution is heavily skewed towards the top
All table numbers are series: 474
How to read this table
The table rows differ by type of medicine or medical material. Some items are repeated with different codes due to the variety of dosage forms and component combinations. To compare production scales, it is important to refer to the values in the 'November 2021' and 'Period since the beginning of the reporting year' columns, as they reflect both current output and cumulative results for the year. The codes allow precise identification of each product group for internal accounting and external audits
What is visible in these numbers
The dataset includes the following indicators: Code (OKPD2, OKEI, OKATO); Reporting month; Previous month; Period from the beginning of the reporting year
Cells with numbers 100 out of 100 (100%) — there are practically no missing values
More in the section Industrial production»
Period and application
The data are drawn from the monthly cut for November 2021. Rosstat updates such tables regularly, enabling analysis of changes in production volumes. These data will be useful to pharmaceutical enterprises for assessing current demand, as well as to analysts and government bodies when shaping health and industrial policy
How it is calculated
Production volumes are used to judge capacity utilization in the industry, calculate the market capacity for components, and determine where to make proposals
Did you notice an error in this table? The parser is wrong, and most often one correction fixes many pages
Report an error Typo is easier this way: highlight it and press Ctrl + Enter